Target Name: DIPK1C
NCBI ID: G125704
Other Name(s): FNCAD | protein FAM69C | divergent protein kinase domain 1C | C18orf51 | FAM69C | DIK1C_HUMAN | family with sequence similarity 69 member C | familial non-conventional Alzheimer's dementia | Divergent

Understanding The Role of DIPK1C in Glycine Cleavage and Disease

DIPK1C (Dipeptidyl-prolyl hydroxylase K1C) is a gene that encodes a protein known as DIPK1C. The protein is a key enzyme in the glycine cleavage pathway, which is a critical step in the synthesis of many proteins. DIPK1C is also known as FNCAD (fancy name for the enzyme), and it is expressed in many different tissues and cells throughout the body.

One of the unique features of DIPK1C is its specificity for the cleavage of the amino acid glycine. Glycine is a highly reactive amino acid that is involved in many different cellular processes, including the regulation of protein function, cell signaling, and inflammation. DIPK1C is specifically interested in the cleavage of glycine by other proteins, and it plays a crucial role in the regulation of the levels of this amino acid in the body.

DIPK1C is a protein that is expressed in many different tissues throughout the body, including the brain, heart, liver, and muscle. It is also highly expressed in the placenta, which is a critical organ that supports the growth and development of fetuses. DIPK1C is thought to be involved in the regulation of many different cellular processes, including the cell cycle, cell signaling, and inflammation.

One of the most promising aspects of DIPK1C is its potential as a drug target. The cleavage of glycine by DIPK1C has been shown to play a role in the regulation of cellular processes that are often disrupted in many diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, DIPK1C has been identified as a potential drug target for a variety of diseases.

In addition to its potential as a drug target, DIPK1C has also been shown to be a valuable biomarker for many different diseases. The cleavage of glycine by DIPK1C is often altered in many diseases, and changes in the levels of this amino acid have been observed in a wide range of conditions, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, DIPK1C has been used as a biomarker for many different diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In conclusion, DIPK1C is a gene that encodes a protein that is expressed in many different tissues throughout the body. It is specifically interested in the cleavage of the amino acid glycine and plays a crucial role in the regulation of this amino acid in the body. In addition to its potential as a drug target, DIPK1C has also been shown to be a valuable biomarker for many different diseases. Further research is needed to fully understand the role of DIPK1C in cellular processes and its potential as a drug and biomarker.

Protein Name: Divergent Protein Kinase Domain 1C

More Common Targets

DIPK2A | DIPK2B | DIRAS1 | DIRAS2 | DIRAS3 | DIRC1 | DIRC3 | DIRC3-AS1 | DIS3 | DIS3L | DIS3L2 | DISC1 | DISC1FP1 | DISC2 | Disintegrin and Metalloproteinase domain-containing protein (ADAM) (nospecified subtype) | DISP1 | DISP2 | DISP3 | DIXDC1 | DKC1 | DKFZp434L192 | DKFZp451A211 | DKFZp451B082 | DKFZP586I1420 | DKK1 | DKK2 | DKK3 | DKK4 | DKKL1 | DLAT | DLC1 | DLD | DLEC1 | DLEU1 | DLEU2 | DLEU2L | DLEU7 | DLEU7-AS1 | DLG1 | DLG1-AS1 | DLG2 | DLG3 | DLG3-AS1 | DLG4 | DLG5 | DLG5-AS1 | DLGAP1 | DLGAP1-AS1 | DLGAP1-AS2 | DLGAP1-AS5 | DLGAP2 | DLGAP3 | DLGAP4 | DLGAP5 | DLK1 | DLK2 | DLL1 | DLL3 | DLL4 | DLST | DLSTP1 | DLX1 | DLX2 | DLX2-DT | DLX3 | DLX4 | DLX5 | DLX6 | DLX6-AS1 | DM1-AS | DMAC1 | DMAC2 | DMAC2L | DMAP1 | DMBT1 | DMBT1L1 | DMBX1 | DMC1 | DMD | DMGDH | DMKN | DMP1 | DMPK | DMRT1 | DMRT2 | DMRT3 | DMRTA1 | DMRTA2 | DMRTB1 | DMRTC1 | DMRTC1B | DMRTC2 | DMTF1 | DMTF1-AS1 | DMTN | DMWD | DMXL1 | DMXL2 | DNA ligase | DNA Methyltransferase (DNMT)